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Induced pluripotent stem (iPS) cells can be obtained
from fibroblasts upon expression of Oct4, Sox2, Klf4,
and c-Myc. To understand how these factors induce
pluripotency, we carried out genome-wide analyses
of their promoter binding and expression in iPS and
partially reprogrammed cells. We find that target
genes of the four factors strongly overlap in iPS
and embryonic stem (ES) cells. In partially repro-
grammed cells, many genes co-occupied by c-Myc
and any of the other three factors already show
an ES cell-like binding and expression pattern. In
contrast, genes that are specifically co-bound by
Oct4, Sox2, and Klf4 in ES cells and encode pluripo-
tency regulators severely lack binding and transcrip-
tional activation. Among the four factors, c-Myc
promotes the most ES cell-like transcription pattern
when expressed individually in fibroblasts. These
data uncover temporal and separable contributions
of the four factors during the reprogramming process
and indicate that ectopic c-Myc predominantly acts
before pluripotency regulators are activated.
INTRODUCTION
Reprogramming of human and mouse fibroblasts to induced
pluripotent stem (iPS) cells has been achieved by the expression
of only four transcription factors, Oct4, Sox2, Klf4, and c-Myc,
subsequently referred to as the ‘‘four factors’’ (Maherali et al.,
2007; Okita et al., 2007; Takahashi et al., 2007; Takahashi and
Yamanaka, 2006; Wernig et al., 2007; Yu et al., 2007). iPS cells
hold great promise for the study and therapy of human diseases
(Dimos et al., 2008; Park et al., 2008) because they are highly364 Cell 136, 364–377, January 23, 2009 ª2009 Elsevier Inc.similar to embryonic stem (ES) cells in their ability to self-renew
and give rise to all three germ layers. Molecularly, reprogram-
ming results in the remodeling of the somatic cell transcription
and chromatin programs to the ES-like state, including the
reactivation of the somatically silenced X chromosome,
demethylation of the Oct4 and Nanog promoter regions, and
genome-wide resetting of histone H3 lysine 4 and 27 trimethyla-
tion (Maherali et al., 2007; Takahashi et al., 2007; Wernig et al.,
2007). A key question raised by transcription factor-induced
reprogramming is how the four factors act to bring about this
change.
Two studies demonstrated that reprogramming of murine
fibroblasts is a gradual process that follows a defined series of
molecular events (Brambrink et al., 2008; Stadtfeld et al.,
2008). Upon retroviral transduction of the factors fibroblast-
specific genes become repressed, exemplified by the
downregulation of the somatic marker Thy1, followed first by
the activation of embryonic markers such as alkaline phospha-
tase (AP) and SSEA1 and later by the induction of pluripotency
genes such as Nanog and Oct4. While Thy1 downregulation
occurs in the majority of cells, gain of SSEA1 and activation of
pluripotency regulators happens with very low efficiency,
suggesting that as yet unknown epigenetic barriers need to be
overcome to induce pluripotency (Huangfu et al., 2008; Meissner
et al., 2007; Mikkelsen et al., 2008).
In ES cells, chromatin immunoprecipitation (ChIP) experi-
ments have demonstrated that Klf4, Sox2, and Oct4 together
with other ES-specific transcription factors such as Nanog often
co-occupy target genes, including their own promoters, which
suggests that they cooperate in regulatory feedback loops to
maintain self-renewal and pluripotency (Boyer et al., 2005;
Chen et al., 2008; Jiang et al., 2008; Kim et al., 2008; Loh
et al., 2006). These transcription factors can function both as
activators of self-renewal and pluripotency genes and as repres-
sors of lineage commitment genes, suggesting that they could
activate the ES-specific transcription program and repress
fibroblast expression during reprogramming. Based on limited
target overlap in ES cells, it was proposed that the function of
c-Myc differs from that of Oct4, Sox2, and Klf4 (Chen et al.,
2008; Kim et al., 2008). However, to date no studies have been
performed to analyze how the four factors bind and function in
iPS cells. It is conceivable that they have a different binding
pattern in these cells, given their diverse origin. It is also possible
that they fulfill transient roles during reprogramming that cannot
be inferred from the analysis of the pluripotent end state and
necessitate the study of intermediate stages of the process.
Understanding the contribution of each factor to the different
steps of reprogramming and an in-depth characterization of
the iPS state should shed light on the molecular nature of repro-
gramming.
Here, we studied the function of the four factors at three stages
of the reprogramming process: the initial phase, an intermediate
step represented by partially reprogrammed cell lines, and the
final iPS cell stage. Partially reprogrammed cells express
markers of the intermediate reprogramming stage and have
failed to transcriptionally activate pluripotency regulators but
can be converted to a pluripotent state with small molecules
that affect chromatin modifications or modulate signal transduc-
tion (Silva et al., 2008; Mikkelsen et al., 2008). By comparing
binding of the factors and expression changes at the three
stages, our analysis provides insight into the specific contribu-
tion of each factor to the reprogramming process.
RESULTS
The Four Factors Bind Similar Sets of Target Genes
in iPS and ES Cells
To characterize the completely reprogrammed state, we used
ChIP and microarrays to determine the promoter regions that
are bound by the four factors in two ES and two iPS cell lines
and compared binding patterns between these cell types. The
iPS cell lines analyzed here (clones 1D4 and 2D4) have
completely suppressed retroviral transgene expression and
entered a self-sustaining pluripotent state that can give rise to
adult chimeras with germline contribution (Maherali et al.,
2007). For each factor, binding between the two iPS cell lines
is as highly correlated as between the two ES cell lines (Table
S1). Hence, the replicate data sets were averaged before deter-
mining bound genes for each factor and cell type (all averaged
binding data are provided in Table S2 and raw data files are
summarized in Table S3, available online). A gene was called
bound using an algorithm that considers information of neigh-
boring probes (Experimental Procedures; Boyer et al., 2005). It
should be noted that genes that fall below the threshold for being
called bound might still be targeted by the various factors,
perhaps transiently, reflecting weaker binding events. However,
we use the phrase ‘‘bound’’ gene to refer to only those genes that
passed our binding criteria. The reliability of our binding calls was
validated by a comparison of our ES cell targets to previously
published observations (Boyer et al., 2005; Chen et al., 2008;
Jiang et al., 2008; Kim et al., 2008; Loh et al., 2006). For example,
a gene ontology (GO) analysis indicated that c-Myc targets in ES
cells include many metabolic regulators while Oct4, Sox2, and
Klf4 targets are skewed toward transcriptional regulators ofdevelopment and differentiation; and the known DNA-binding
motifs for Oct4, Sox2, Klf4, and c-Myc are highly enriched in
the promoter regions that are targeted by these factors (data
not shown). Furthermore, real-time PCR analysis confirmed
strong enrichments at loci that were called bound (Figure S1),
and bound targets identified in merged data sets were reliably
found in the individual replicates indicating high reproducibility
of the data (Figure S2A).
The four factors exhibit overall similarity in their binding
between ES and iPS cells at the genome-wide level (Figure 1A).
The number of target genes co-occupied by three or all four
factors in iPS cells is much higher than expected by random
chance (476 genes), and the number of targets bound by just
one factor is much lower (1681 genes, c2 test p = 0.0057,
Figure 1B), like in ES cells (Chen et al., 2008; Kim et al., 2008).
Notably, while we found 794 genes bound by c-Myc alone,
approximately half of the genes that are occupied by multiple
transcription factors (548 genes) are also targets of this factor
(Figure 1C), suggesting that, surprisingly, c-Myc coregulates
many genes together with the other three factors in iPS cells
(c2 test p = 1.9 e291).
To analyze co-occupancy by the four factors inmore detail, we
classified target genes according to the combination of factors
bound. This categorization yielded a total of 15 groups, with
one group containing genes bound by all four factors (single
letter code OSCK for Oct4, Sox2, c-Myc, and Klf4), four groups
with genes bound by different combinations of three factors
(OSC, OSK, OCK, and SCK), six groups of genes that are bound
by two factors (OS, OC, OK, SC, SK, and CK), and four gene
groups that are bound by only one (Figure S3). Next, we asked
whether genes that are bound by a particular combination of
factors in iPS cells are associated with the same set of factors
in ES cells and vice versa (Figures 1D and S4). Across all 15
groups, the binding pattern is similar between the two cell types.
Focusing on the groups of genes co-bound by three or four
factors (Figure 1D), up to 64% of ES cell targets are bound by
the same sets of factors in iPS cells (Figure 1D, section a).
However, the binding pattern is not identical because there are
genes that are bound by fewer factors in iPS cells than in ES cells
(Figure 1D, section b1), as there are genes bound by fewer
factors in ES cells than in iPS cells (Figure 1D, section b2). Never-
theless, only very few genes that are associatedwith three or four
factors in ES cells are not bound by any factor in iPS cells and
vice versa. Indeed, when allowing differential binding by one
factor between ES and iPS cells, up to 87% of the genes are
bound by comparable sets of factors. These findings also apply
to genes bound by two factors (Figure S4A). Interestingly, genes
that are bound by a specific factor in one cell type but not in the
other have a lower binding strength than those genes that are
bound in both cell types (Figures 1D, S2, and S4A), supporting
the notion that binding patterns in iPS and ES cells are highly
conserved. Furthermore, target genes are similarly expressed
in both cell types, suggesting that differences in factor binding
are too small to dramatically affect transcription (Figures 1D
and S4A).
The similarity of binding events between both cell types is
further reflected by analogous functional classifications for
genes in the 15 binding groups in iPS and ES cells (Figure S3).Cell 136, 364–377, January 23, 2009 ª2009 Elsevier Inc. 365
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Figure 1. Target Overlap between ES and iPS Cells
(A) Pearson correlation of binding strength at the probe level for each factor between iPS and ES cells across all genes.
(B) Bar chart indicates the number of genes observed to be bound by only one, any combination of two or three, and all four factors in iPS cells (light gray) and the
expected number of target genes calculated assuming that each factor binds independently of the others (dark gray).
(C) Pie charts indicate the number and proportion of target genes bound by single or multiple factors in iPS or ES cells, divided according to the pres-
ence of c-Myc.
(D) Comparison of binding patterns in ES and iPS cells for genes bound by the indicated combination of three or four factors (denoted by single letter nomenclature
withO=Oct4, S =Sox2, C= c-Myc, andK=Klf4). The three segments of each cluster are based on the overlap of binding events between ESand iPS cells: section
(a) depicts genes bound by the same set of factors in ES and iPS cells, (b1) and (b2) contain genes that have binding by additional and/or fewer factors in either cell
type. Binding of a gene ismarked by a dark (ES) or light gray block (iPS). Heat maps plot the corresponding binding strength. For each factor, the lowest maximum366 Cell 136, 364–377, January 23, 2009 ª2009 Elsevier Inc.
For both cell types, GO analysis demonstrates that genes asso-
ciated with c-Myc, by itself or in combination with the other
factors, are significantly enriched for regulators of metabolic
processes including the control of translation, RNA splicing,
cell cycle, and energy production, while genes bound by combi-
nations of Oct4, Sox2, and Klf4, in the absence of c-Myc, are
mainly implicated in transcriptional control of development.
Together, these data indicate that Oct4, Sox2, Klf4, and c-Myc
binding patterns in iPS cells resemble those of ES cells, suggest-
ing that pluripotency relies on binding of the four factors to
a conserved set of target genes. The extensive co-binding
among all four factors indicates that c-Myc participates in the
transcriptional network formed by Oct4, Sox2, and Klf4 much
more than expected.
Extensive Failure to Activate ES-like Expression
in Partially Reprogrammed Cells
To begin to understand events that occur during the reprogram-
ming process, we decided to analyze partially reprogrammed
cell lines. These cells emerge at intermediate stages of reprog-
ramming, when reprogrammed cells are selected based on
morphology or reporter expression, and have been informative
for understanding the barriers of the reprogramming process
(Meissner et al., 2007; Mikkelsen et al., 2008; Takahashi and
Yamanaka, 2006). We selected two stable, clonal, partially
reprogrammed cell lines for our analysis (1A2 and 1B3) that
were previously derived from female fibroblasts carrying a
GFP/puromycin resistance reporter cassette under the control
of the endogenous Nanog promoter (Maherali et al., 2007;
Figure S5). These partially reprogrammed cells have an ES-like
morphology surrounded by a few round cells, are positive for
SSEA1, and, similar to ES cells, have a doubling time of 13 hr
(Figure S5). The four factors are expressed from the exogenous
retroviral constructs, and endogenous pluripotency regulators
such as Nanog and Oct4 and the inactive X chromosome are
not reactivated (Figure S5). These cell lines can be maintained
in culture without a change in morphology, and the expression
profile of a pool of 10 colonies is highly similar to that of the pop-
ulation demonstrating homogeneity (Figure S6). A small fraction
of GFP-positive, i.e., highly Nanog-expressing, cells (1%) that
support chimerism stochastically arises in these cell lines
(Figure S6; Maherali et al., 2007), and upon addition of a specific
MEK inhibitor used in recent reprogramming experiments (Silva
et al., 2008) an efficient transition to GFP-positive colonies
is observed (Figure S6). These data demonstrate that our
partially reprogrammed cells reflect an intermediate stage of
the reprogramming process that can transition to the completely
reprogrammed iPS state.
We first characterized the gene expression pattern of the two
partially reprogrammed cell lines. They are highly similar in
expression to those analyzed recently by Mikkelsen et al. (Mik-
kelsen et al., 2008), even when derived from somatic cells other
than fibroblasts, supporting the idea that partially reprogrammedcells are trapped at a common intermediate state (Figure S6).
Fibroblast-specific genes are more efficiently downregulated in
partially reprogrammed cells (correlation ES/MEF: partial/MEF =
0.628) than ES-specific genes are activated (correlation ES/MEF:
partial/MEF = 0.324; Figure S7, Table S4). A GO analysis revealed
that ES-specific metabolic regulators are more completely
activated in partial reprogrammed cells than transcriptional
regulators (Figure S7), in agreement with the observation that
key transcriptional regulators of pluripotency are turned on
only during the final steps of the reprogramming process (Bram-
brink et al., 2008; Stadtfeld et al., 2008).
Four Factor Binding in Partially Reprogrammed Cells
To address whether differential gene expression between
partially reprogrammed cells and ES cells is due to binding of
the four factors to different sets of genes, we determined their
target genes in both partially reprogrammed cell lines. Analo-
gous to expression, binding is highly correlated between these
cell lines supporting the notion that these cells represent a stable
and homogenous intermediate reprogramming state (Table S1).
We therefore merged binding data from both cell lines to
generate the set of bound genes and found that the genome-
wide binding of each factor is much less conserved between
ES cells and partially reprogrammed cells than between iPS
and ES cells (Figure 2A, compare with 1A).
To study the relationship of factor binding and expression in
detail, we focused on the 3744 genes that are more than 2-fold
differentially expressed between partially reprogrammed cells
and ES cells (Figure 2B, Table S1). Approximately one-third of
these genes (1139 genes) are direct binding targets of the
factors. Genes that aremore highly expressed in partially reprog-
rammed cells than in ES cells are often bound by more factors in
the intermediate state than in ES cells. In contrast, genes that are
more highly expressed in ES cells often are bound by fewer
factors in partially reprogrammed cells than in ES cells
(Figure 2B). The higher the amplitude of differential expression
the more factors tend to be differentially bound between ES
and partially reprogrammed cells (Figure 2B), suggesting that
binding by multiple factors leads to stronger transcriptional
activation. These data imply that genes are more strongly ex-
pressed in partially reprogrammed cells compared to ES cells
due to targeting of the four factors to promoter regions that
they do not normally bind in ES cells, and conversely that the
failure to activate ES cell-specific genes results from the lack
of binding of the factors in partially reprogrammed cells. Differ-
ential binding of the factors in partially reprogrammed cells is
also reflected by a different spectrum of functional classifica-
tions for target genes in partially reprogrammed cells (Figure S3).
It is critical to understand why the four factors target different
genes in partially reprogrammed cells than in ES cells. We found
that promoter regions bound uniquely in partially reprogrammed
cells contain the known DNA-binding motif for the occupying
factor, suggesting that targeting to these genes in partiallybinding strength among all genes and cell types analyzed in this study was set to the darkest red color. For each binding cluster, expression ratios of ES cells/
fibroblasts (MEFs) (yellow star) and iPS/ES cells (red star) and the Pearson correlation coefficient comparing expression of the genes within a cluster between
ES and iPS cells are given (top).Cell 136, 364–377, January 23, 2009 ª2009 Elsevier Inc. 367
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Figure 2. Differential Binding between Partially Reprogrammed Cells and ES Cells Correlates with Expression Differences
(A) Pearson correlation of binding strength at the probe level for each factor between ES cells and partially reprogrammed cells across all genes.
(B) The heat map in the Exp column depicts the log2 expression ratio between partially reprogrammed cells (piPS) and ES cells for genes more than 2-fold differ-
entially expressed between these cell types. For these genes, +Binding columns illustrate binding events in partially reprogrammed cells that were not found in ES
cells (in red), with +1 to +4 indicating the number of factors that were bound in partially reprogrammed cells but not in ES cells and the letter indicating the factor
(Oct4 [+O], Klf4 [+K], Sox2 [+S], or c-Myc [+C]). Similarly, in Binding columns, genes that were bound in ES cells but not in partially reprogrammed cells are
marked in green, with 1 to 4 indicating the number of factors that were bound in ES cells and not in partially reprogrammed cells and the letter indicating
the factor. Binding differences for the most differentially expressed genes between ES and partially reprogrammed cells are presented in a zoomed view to
the right and graphs to the far right plot log2(IP/input) ratios of probes over the 8 kb promoter region for one gene from each subgroup.
(C) For binding events found in partially reprogrammed cells but not ES cells, bound regions were scanned for the presence of the DNA-binding motifs of the four
factors (with the Ebox motif being bound by c-Myc). Significantly enriched motifs are indicated.368 Cell 136, 364–377, January 23, 2009 ª2009 Elsevier Inc.
reprogrammed cells is not simply due to nonspecific or indirect
binding but instead may be guided by direct interactions with
their respective DNA-binding motif (Figure 2C). Given that the
expression of the four factors is 3- to 8-fold higher in partially
reprogrammed cells than in ES or iPS cells, these sites are
perhaps low-affinity binding sites. In contrast, promoter regions
that are bound in ES cells but not in partially reprogrammed cells
may need other proteins that are not expressed in partially
reprogrammed cells to allow cooperative binding of the factors.
One such candidate is the transcription factor Nanog, which
colocalizes with Oct4 and Sox2 at a subset of promoter regions
in ES cells (Boyer et al., 2005; Chen et al., 2008; Kim et al., 2008)
and is not expressed in our partially reprogrammed cell lines
(Figure S5). Indeed, we found that genes that lack ES-like
binding by the factors in partially reprogrammed cells are more
often targets of Nanog in ES cells than genes where binding
uniquely occurs in partially reprogrammed cells (Figure 2D). In
particular, genes that are bound by three or four factors in ES
cells and completely lack binding in partially reprogrammed cells
are often Nanog targets in ES cells (Figure 2D). Thus, the
absence of Nanog, and likely that of other transcription factors,
could contribute to the lack of ES-specific binding in partially
reprogrammed cells.
Oct4, Sox2, and Klf4 Targeting Is Particularly Impaired
in Partially Reprogrammed Cells
Partially reprogrammed cells have fewer bona fide ES cell
targets than iPS cells for Oct4 (38% of its ES cell targets are
bound in partially reprogrammed cells versus 79% in iPS cells),
Sox2 (35% versus 54%), and Klf4 (38% versus 67%), while
c-Myc binds 67% in partially reprogrammed cells and 59% of
its ES targets in iPS cells. Thus there is a widespread difference
in binding between ES cells and partially reprogrammed cells
that impinges more on Oct4, Sox2, and Klf4 than on c-Myc.
This observation led us to address whether c-Myc co-occu-
pancy affects binding of the other three factors. We found that
Oct4, Sox2, and Klf4 binding in partially reprogrammed cells is
more similar to their binding in ES cells when c-Myc is co-bound
at the promoter (Figure 3A). For example, 48% of Oct4 ES cell
targets are bound in partially reprogrammed cells when the
target is co-bound by c-Myc in ES cells, compared to only
32% when co-binding in ES cells occurs with Klf4 and/or
Sox2. Thus, c-Myc association divides ES cell target genes of
the four factors into two groups and appears to be a measure
of their targeting efficiency in partially reprogrammed cells. The
difference in Oct4, Sox2, and Klf4 binding based on c-Myc co-
occupancy is not observed when ES and iPS cell binding is
compared (Figure 3A).
To further analyze these binding differences, wemeasured the
average number of factors differentially bound between iPS cells
and partially reprogrammed cells for genes in each ES cell
binding group (Figure 3B). The most significant differences in
binding between iPS and partially reprogrammed cells exist in
those genes that are co-occupied by Oct4, Sox2, and Klf4
(OSK), followed by genes associated with both Oct4 and Klf4
(OK). Genes bound by all four factors (OSCK) or Oct4 and
Sox2 (OS) just pass the significance threshold. In general, genes
in these groups also have the lowest correlation in expression
between pluripotent and partially reprogrammed cells
(Figure 3B). Genes bound by OSK are characterized by high
binding strength in ES and iPS cells and largely unbound in
partially reprogrammed cells (Figure 3C). Indeed, with only 24
OSK target genes in partially reprogrammed cells compared to
193 genes in iPS cells and 129 in ES cells, co-occupancy by
OSK hardly exists in partially reprogrammed cells. These data
show that there is widespread differential binding between iPS/
ES cells and partially reprogrammed cells that most dramatically
occurs in genes occupied by OSK. This finding was confirmed
when differential binding between ES/iPS and partially reprog-
rammed cells was similarly analyzed for genes in each iPS-
specific binding group (data not shown).
Oct4, Sox2, and Klf4 Co-occupancy Is Associated
with Strong Transcriptional Activation
Genes co-occupied by OSK in ES cells, on average, have the
highest increase in expression between iPS cells and fibroblasts,
i.e., upon reprogramming (Figure 4A). As expected, these genes
are not upregulated to the ES/iPS cell level in partially repro-
grammed cells. In particular, OSK targets that aremost activated
in the transition of fibroblasts to iPS cells are the ones that fail to
be induced (Figure 4B). These genes are not bound in partially re-
programmed cells and include highly expressed regulators of the
pluripotent state (for example, Tcl1, Dppa3, Dppa4, Dppa5) and
embryonic development (for example, Foxh1, Lefty2) (Figure 4C).
The expression analysis also revealed that the four factors
appear to have a larger impact on the activation of gene expres-
sion because co-bound genes are usually more highly ex-
pressed in iPS and ES cells than in fibroblasts (Figure 4A). These
findings also extend to the partially reprogrammed state (data
not shown) indicating that an intrinsic property of reprogramming
factor co-binding is to activate genes, irrespective of the cell
type. Consistent with published observations (Chen et al.,
2008; Kim et al., 2008), genes occupied by only c-Myc are
activated more strongly than those bound singly by Oct4,
Sox2, or Klf4.
Binding Is Incompatible with Low Histone
H3K4 Trimethylation
We reasoned that the chromatin state of promoter regions could
influence the binding properties of the factors during reprogram-
ming. In general, transcribed genes are marked by the ‘‘acti-
vating’’ histone H3 lysine 4 trimethylation (H3K4me3), while
repressed genes, especially those encoding developmental
regulators, are associated with histone H3 lysine 27 trimethyla-
tion (H3K27me3). In repressed genes, H3K27me3 is often found
in combination with H3K4me3 forming bivalent chromatin
(D) Genes bound by fewer factors in partially reprogrammed cells than in ES cells (Binding) or by more factors (+Binding) were divided according to the number
of factors differentially bound between these cell types. The number of genes per group and the fraction of these genes that is bound by Nanog in ES cells are
presented. Significance was computed using the difference of proportions test.Cell 136, 364–377, January 23, 2009 ª2009 Elsevier Inc. 369
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Figure 3. OSK Targets Are Most Differentially Bound between iPS Cells and Partially Reprogrammed Cells
(A) Genes bound by two, three, or four factors in ES cells were divided into those co-occupied by c-Myc and those lacking c-Myc. For both groups of genes, the
bar plot presents the fraction of Oct4, Sox2, or Klf4 ES targets that are bound by the respective factor in partially reprogrammed cells (piPS) or iPS cells. Signif-
icant differences for binding in piPS, computed using the difference of proportions test, are indicated.
(B) The graph displays the average number of factors differentially bound between iPS and partially reprogrammed cells for target genes grouped according to
their factor association in ES cells (given to the left), within a 95% confidence interval. Filled squares reflect the relative numbers of genes in each target group.
Significance was determined using the binomial distribution. Pearson correlation coefficients (Exp Cor) for expression between ES and partially reprogrammed
cells (piPS) were computed for genes in each group and for those genes in a given group that are expressed at least 2-fold higher in ES cells compared to MEFs.
(C) Binding calls and binding strength heatmaps of Oct4, Sox2, c-Myc, and Klf4 in ES cells, iPS cells, and partially reprogrammed cells (piPS, lightest gray) for
OSK ES targets as described in Figure 1D.domains (Bernstein et al., 2006). Our previous analysis demon-
strated that these histone methylation marks are reset to the
ES cell pattern in iPS cells (Maherali et al., 2007). To test the rela-
tionship between promoter histone methylation and binding of
the four factors, we analyzed H3K4me3 and H3K27me3 patterns
in fibroblasts, partially reprogrammed cells, and iPS and ES cells
for all promoter regions bound by the four factors.
We found that the differential binding of the four factors
between partially reprogrammed cells and ES/iPS cells cannot
generally be explained by differences in K4 and K27 methylation370 Cell 136, 364–377, January 23, 2009 ª2009 Elsevier Inc.patterns between the pluripotent cells, partially reprogrammed
cells, or fibroblasts. Specifically, the proportion of genes en-
riched forK27methylation in EScells andpartially reprogrammed
cells is similar for ES cells targets (Figure 5A) indicating that the
presence of H3K27me3 per se does not interfere with binding
of the factors. Similarly, the majority of ES cell targets of the
four factors are methylated at K4 in ES cells, a pattern that is
also observed in fibroblasts (Figure S8) and partially repro-
grammed cells (data not shown). We noted that c-Myc, alone or
with other factors, mainly associates with genes that have less
repressive chromatin given that they are methylated at K4 and
lackK27methylation in all cell types including fibroblasts (Figures
S8 and 5A). This result potentially explains why c-Myc binds in
a more ES-like pattern in partially reprogrammed cells.
When specifically analyzing the methylation pattern in OSK
cell ES targets (Figure 5B), we found a distinct histone meth-
ylation signature for genes that are most dramatically upregu-
lated between ES/iPS cells and fibroblasts. Characterized by
high H3K27me3 and low H3K4me3 enrichment in fibroblasts,
these genes are strongly positive for H3K4me3 and have
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Figure 4. OSK Targets Are Most Differentially
Expressed between ES/iPS Cells and Partially
Reprogrammed Cells
(A) Bar chart depicting themean of the log2 expression
ratio between the ES (black), iPS (dark gray), or
partially reprogrammed cells (piPS, light gray) and
fibroblasts (MEF) for genes bound by the indicated
combination of factors in ES cells or for all unbound
genes (None).
(B) The graph divides OSK targets of ES cells accord-
ing to their expression ratio between indicated cell
types.
(C) Venn diagram depicting genes bound by OSK in
iPS and ES cells but not in partially reprogrammed
cells (piPS) (left), genes bound in partially reprog-
rammed cells but not in ES and iPS cells (right), and
genes bound by OSK in all three cell types (overlap-
ping area). Circles are scaled and colored according
to the expression difference between iPS cells and
piPS.
lost H3K27me3 in ES/iPS cells in accor-
dance with their high transcriptional activa-
tion (Figure 5B, highlighted genes). In
partially reprogrammed cells, this set of
genes exhibits an intermediate pattern of
histone methylation and has a severe lack
of binding of the three factors (Figure 5B).
A similar pattern of histone methylation
change is also evident in a subset of OK,
OS, and OSCK bound target genes that
exhibit a strong induction of expression
during reprogramming (data not shown
and Figure S8). Together, these data indi-
cate that highly expressed targets of the
factors, which encode many important
regulators of pluripotency and embryonic
development (Figure 5B), are characterized
by a specific histone H3K4/K27 methylation
pattern that may be related to the lack of
binding by the factors in partially reprog-
rammed cells.
c-Myc Is a Major Contributor to Initial
Reprogramming Events
Our analysis of binding and expression in
partially reprogrammed cells suggested
that c-Myc does not greatly contribute to
the activation of pluripotency regulators. Next, we wanted to
directly test the contribution of each factor to the early phase
of the reprogramming process and followed the levels of the
somatic surface marker Thy1 upon retroviral expression of
a single factor in fibroblasts. Within 2 days of infection, the pop-
ulation of Thy1-positive fibroblasts decreased most dramatically
in cells expressing only c-Myc, and by day 4, more than half of
those cells had lost the Thy1 marker (Figure 6A). This strong
effect was not seen in fibroblasts infected with Klf4, Oct4, or
Sox2 (Figure 6A) although the infection efficiency of each virusCell 136, 364–377, January 23, 2009 ª2009 Elsevier Inc. 371
Figure 5. A Distinctive HistoneMethylation Pattern for OSK Target Genes that AreMost Dramatically Upregulated in ES/iPS Cells Compared
to Fibroblasts
(A) Bar chart depicts the fraction of genes with enrichment of histone H3 K27 trimethylation in their promoter regions in different cell types, for genes that are
bound by the indicated combination of factors in ES cells.
(B) Hierarchical clustering of histone H3 K4 and K27 trimethylation patterns in ES cells, iPS cells, partially reprogrammed cells (piPS), and fibroblasts for genes
bound by OSK in ES cells. Each row represents the methylation pattern along the5.5 kb to +2.5 kb promoter region relative to the transcription start site (TSS),
reiterated eight times to present the data for each cell type andmethylation mark. Each 8 kb promoter region is divided into sixteen 500 bp fragments that display
the average log ratio of probe signal intensity with green, red, and gray representing lower-than-average, higher-than-average, andmissing values for enrichment
due to lack of probes in those regions, respectively. Binding of the factors in ES (dark gray), iPS (light gray), and partially reprogrammed cells (lightest gray) is
presented to the right of the histone methylation data. Two sets of log2 expression ratios are appended (ES/MEF and piPS/ES) and genes most highly expressed
in ES cells relative to MEF are marked and listed.was approximately the same (data not shown). When the four
factors were added to fibroblasts in combinations, Thy1 downre-
gulation was most affected when c-Myc and Klf4 were included
in the mixture (Figure S9A). Collectively these results demon-
strate that c-Myc mediates downregulation of the fibroblast
marker most efficiently among the four factors.
To determine if this observation applies genome-wide, we
investigated global expression changes that occur in fibroblasts
upon individual expression of c-Myc, Klf4, Sox2, or Oct4.We first
established an inducible expression system that allowed us to
start with a homogenous population of fibroblasts expressing
one factor. The factors, under the control of a doxycycline-
inducible promoter, were cloned into a retroviral vector that
included a hygromycin resistance gene. Fibroblasts heterozy-
gous for the reverse tetracycline transactivator in the constitu-
tively active Rosa26 locus (R26 rtTA/WT) were infected with
individual inducible viruses, selected for hygromycin resistance,
and 3 days after addition of doxycycline profiled for expression,
along with an uninfected control. Addition of doxycycline
resulted in the expression of the factors in almost 100% of the372 Cell 136, 364–377, January 23, 2009 ª2009 Elsevier Inc.
cells (data not shown). In agreement with the Thy1 result, c-Myc-
induced expression changes resembled those found between
ES cells and fibroblasts most closely when compared to the
effects of the other three factors (Figure 6B), for genes that
become both up- and downregulated between ES cells and
fibroblasts (Figure 6C). Furthermore, the expression changes
upon ectopic c-Myc expression are most similar to those occur-
ring in fibroblasts overexpressing all four factors, particularly for
those genes that become repressed (Figure S9B). The genes
downregulated in fibroblasts upon c-Myc expression include
A
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Figure 6. TheRole of c-Myc in Early Steps of the
Reprogramming Process
(A) FACS plots showing Thy1 surface levels of fibro-
blasts 2 or 4 days post-infection with a retrovirus
carrying the indicated factor (blue) in comparison to
uninfected fibroblasts (red).
(B) Heatmap of expression differences between ES
cells and fibroblasts (MEFs) and between fibroblast
lines induced for c-Myc, Klf4, Oct4, or Sox2 expres-
sion for 3 days with doxycycline relative to an
uninduced fibroblast control, for all genes more than
2-fold differentially expressed between ES cells and
MEFs, ordered by decreasing expression ratio.
(C) Overlap of genes 2-fold up or down between ES/
MEF and 2-fold up or down between MEFs induced
to express Oct4, Sox2, Klf4, or c-Myc and uninduced
MEFs. The first number presents the genes in the over-
lap, the second number the enrichment (described in
Experimental Procedures), and the third number
log10 of the p value. Significant enrichments are high-
lighted in green.
(D) R26 rtTA/WT fibroblasts were infected with three
constitutively expressed retroviruses (const) and
a dox-inducible retrovirus for the fourth factor (tet).
Doxycycline (dox) was added until the indicated day
and AP-positive colonies scored on day 25.
collagens and are involved in signaling and
organ development. Together with the anal-
ysis of factor binding and expression in the
partially and completely reprogrammed
states, these results indicate that c-Myc
enhances early steps of reprogramming by
repressing fibroblast-specific expression
and upregulating the metabolic program of
the embryonic state.
Previously it was shown that reprogram-
ming only occurs when all four factors are
expressed for at least 8–10 days (Brambrink
et al., 2008; Stadtfeld et al., 2008), but the
temporal requirement for each individual
factor remained untested. Based on our
data, we wanted to test whether ectopical
c-Myc expression is required for a shorter
time period during reprogramming than that
of Oct4, Sox2, and Klf4. R26 rtTA/WT fibro-
blasts were infected with combinations of
retroviruses that allowed the doxycycline-
inducible expression of only one factor and
constitutive expression of the other three. Doxycycline was
added 24 hr post-infection to induce expression of the ‘‘fourth’’
reprogramming factor and subsequently withdrawn at different
time points, leading to efficient downregulation of induced tran-
scripts within 24 hr as determined by real-time PCR (data not
shown). AP-positive colonies were scored 25 days post-infec-
tion as a measure of reprogramming (Figure 6D). Fibroblasts
induced to express c-Myc for 5 days gave rise to AP-positive
colonies that only modestly increased in numbers when c-Myc
expression was maintained for longer periods. In contrast,Cell 136, 364–377, January 23, 2009 ª2009 Elsevier Inc. 373
induction of c-Myc for only 3 days resulted in dramatically
fewer colonies, similar to reprogramming experiments in which
c-Myc is completely omitted (Nakagawa et al., 2008; Wernig
et al., 2008; data not shown), suggesting that a 5 day pulse
of ectopic c-Myc expression is sufficient to obtain c-Myc-
dependent reprogramming. In contrast, exogenous expression
of Oct4 and Klf4 was required for at least 12 days. Surprisingly,
ectopic Sox2 expression for only 5 days was enough to give
rise to AP-positive colonies, although unlike for c-Myc, these
colonies were more heterogeneous in morphology and greatly
increased in number with prolonged exogenous expression,
a result that deserves future investigation. Taken together,
these data indicate that the four factors differ in their contribu-
tion to the reprogramming process and suggest that ectopic
c-Myc is only required initially to attain a high reprogramming
efficiency.
DISCUSSION
This study aimed to uncover the contribution of the repro-
gramming factors to the induction of pluripotency. During the
reprogramming process, fibroblast markers are repressed and
early embryonic markers like SSEA1 are activated before
expression of pluripotency regulators and the self-sustaining
pluripotent state are attained (Brambrink et al., 2008; Stadtfeld
et al., 2008). In agreement with these observations, fibroblast-
specific genes are efficiently silenced in partially reprogrammed
cells, while the embryonic program is not fully induced. Clones
obtained in fibroblast reprogramming experiments with ectopic
expression of only Oct4, Klf4, and c-Myc are also characterized
by repression of fibroblast-specific genes although not to the
same extent as in our four factor-induced partially reprog-
rammed cell lines (Figure S10). Thus, silencing of the somatic
cell expression program appears to be an important initial step
required for the induction of the ES-like expression program.
Our data indicate a major contribution of c-Myc to this first
step. We found that, of the four factors, c-Myc promotes the
most ES-like expression changes, including the repression of
fibroblast-specific genes (Figure 7A, i). Mechanisms by which
c-Myc induces transcriptional repression are much less under-
stood than its function as a transcriptional activator (Wanzel
et al., 2003). Global repressive effects of c-Myc could be
mediated through its interaction with the transcription factor
Miz (Wu et al., 2003) or direct binding and activation of a tran-
scriptional repressor. Interestingly, when murine fibroblasts
were treated for 7 days solely with valporic acid (VPA), a histone
deacetylase inhibitor that can replace c-Myc function during re-
programming, their expression started to resemble an ES-like
state, including the repression of highly transcribed fibroblast-
specific genes (Huangfu et al., 2008). Thus, c-Myc expression
or VPA treatment may lay the framework for the efficient repres-
sion of the somatic expression and induction of the ES cell
expression program.
The comparison of binding patterns of the factors in iPS/ES
cells and partially reprogrammed cell lines further strengthens
the conclusion that the contribution of c-Myc to the reprogram-
ming process is separable from that of the other three factors.
The metabolism-related embryonic expression program is374 Cell 136, 364–377, January 23, 2009 ª2009 Elsevier Inc.induced by binding of combinations of all four factors
(Figure 7A, ii and iii), while the activation of many regulators of
the pluripotent state is dependent on co-binding of only Oct4,
Klf4, and Sox2 (Figure 7A, v), which does not occur in partially re-
programmed cells (Figure 7A, iv). Indeed, ectopic expression of
c-Myc is only required for the first few days of the reprogramming
process.Wepropose that lackofOct4, Sox2, andKlf4 co-binding
in partially reprogrammed cells contributes to the failure to estab-
lish thepluripotent state.During reprogramming,Oct4, Sox2, and
Klf4 can likely only stochastically overcome this binding block
contributing to the low efficiency of this conversion.
An important question is why Oct4, Sox2, and Klf4 cannot
associate with their ES cell target genes in partially repro-
grammed cells. One explanation could be the absence of other
factors, such as Nanog, that allow targeting of the reprogram-
ming factors. These factors could form large complexes neces-
sary for cooperative binding to target genes or could induce
a conformational change of DNA allowing subsequent binding
by Oct4, Sox2, and Klf4. Alternatively, the target promoters
may have repressive chromatin structures that prevent appro-
priate binding of the factors. Indeed, our data demonstrate that
a gain in histone H3K4 methylation is specifically associated
with the activation of many pluripotency regulators (Figure 7B).
In partially reprogrammed cells, the methylation status is not in
an ES-like pattern and the reprogramming factors do not bind
appropriately, suggesting that the establishment of the ES-like
histone methylation pattern is either a requirement for or coin-
cides with the recruitment of the factors. Elucidating how the
methylation pattern transitions to an ES-like state and how
Oct4, Sox2, and Klf4 are recruited to genes encoding pluripo-
tency regulators should allow for the development of more effi-
cient reprogramming strategies.
Interestingly, c-Myc is dispensable for fibroblast reprogram-
ming as both human and murine iPS cells can be obtained in
the absence of c-Myc, albeit with dramatically reduced
efficiency and kinetics (Nakagawa et al., 2008; Wernig et al.,
2008). The fact that activation of transcriptional regulators of
pluripotency is largely independent of c-Myc binding provides
an explanation for why c-Myc is not absolutely required for re-
programming. Our data indicate that reprogramming is delayed
and inefficient in the absence of ectopic c-Myc expression
because c-Myc greatly enhances the initial steps of reprogram-
ming. The fact that Oct4, Sox2, and Klf4 are targeted in a more
ES-like pattern in partially reprogrammed cells to genes that
are co-bound by c-Myc also suggests that its presence facili-
tates the binding of the other factors. In addition, c-Myc normally
fulfills many other functions, for example in regulating DNA
replication (Dominguez-Sola et al., 2007) and global histone
acetylation (Knoepfler et al., 2006), which may facilitate the
reprogramming process more indirectly.
Once reprogramming is complete the binding pattern of the
four factors is similar to thatofEScells, suggesting thatacommon
binding signature has to be achieved to attain pluripotent gene
expression. Differences in binding between these ES and iPS
cells occur generally in genes that are bound more weakly. In
the future, it will be important to determine whether any of these
binding differences reflect an epigenetic memory of the starting
cell population that may influence differentiation behavior.
EXPERIMENTAL PROCEDURES
Cell Culture and Reprogramming Experiments
ES (V6.5 and E14), iPS (1D4 and 2D4), partially reprogrammed cells (1A2 and
1B3), and three primary mouse embryonic fibroblast (MEF) lines derived from
day (d) 14.5 embryos were cultured according to standard methods. Reprog-
rammed cell lines were grown in the presence of 1 mg/ml puromycin. For new
reprogramming experiments, the cDNAs of the four factors were cloned
into the pMX (constitutive expression) and pRetroX-Tight-Hyg (Clontech,
dox-inducible) retroviral vectors, which were individually transfected into PlatE
packaging cells using Fugene (Roche). Viral supernatants harvested
48 hr post-infection were used to infect MEFs in the presence of 10 mg/ml
polybrene. Where indicated, MEFs heterozygous for R26 rtTA were used
and cultures supplemented with 2 mg/ml dox. Dox-containing medium was
changed every 3 days until withdrawal. To obtain expression data upon induc-
tion of only one single factor, R26 rtTA MEFs were infected with the respective
pRetro-virus and selected for 1 week in 100 mg/ml hygromycin before dox
induction.
Flow Cytometry
Thy1-positive fibroblasts were sorted on a FACS ARIA (BD Biosciences) and
subsequently infected. At the indicated time point, cells were harvested,
passed through a 40 mm cell strainer, incubated with PE-conjugated rat anti-
Thy1 antibody (eBiosciences), and analyzed on an LSR cytometer (BD Biosci-
ences) using the FloJo software (TreeStar).
ChIP on Chip
Chromatin fragments associated with the respective transcription factor or
histone mark were immunoprecipitated with specific antibodies (Oct4
[sc5279] and c-Myc [sc764] both SantaCruz, Sox2 [Chemicon 5603], Klf4
[R&D Biosystems AF3158], Nanog [Abcam 21603], H3K4 trimethylation
[Abcam 8580], and K27 trimethylation [Upstate 07-449]) and hybridized on
an Agilent promoter microarray (G4490) as described previously (Maherali
et al., 2007). Probe signals were extracted and normalized using Agilent’s
Feature Extraction and ChIP Analytics software and binding calls made
following a heuristic described previously (Boyer et al., 2005). Briefly, the algo-
rithm takes the p values of two signal measures (normalized log ratio of the
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Figure 7. Role of the Four Factors during Reprogramming
(A) c-Myc is amajor contributor to the downregulation of fibroblast-specific genes at the beginning of the reprogramming process (i). In iPS cells, c-Myc binds and
activates many ES cell-specific genes with roles in metabolic regulation, often with the other three factors (iii). For many of these target genes, binding and acti-
vation is also found in partially reprogrammed cells (ii). Target genes that are co-bound by Oct4, Sox2, and Klf4 in ES/iPS cells encode some of the most highly
expressed regulators of pluripotency (v) and are not bound and activated at the partially reprogrammed state (iv). Our data suggest that the targeting of OSK to
these genes represents a barrier to the reprogramming process and that c-Myc-bound genes largely become activated during earlier steps.
(B) State of histone H3K4 and K27 trimethylation within promoter regions of genes that become most highly activated during reprogramming and that are
co-bound by Oct4, Sox2, and Klf4 in ES/iPS cells but not in partially reprogrammed cells.Cell 136, 364–377, January 23, 2009 ª2009 Elsevier Inc. 375
signal intensity), X and X, as input. X is the signal measure of an individual
probe and X the average signal measure of a probe and its closest upstream
and downstream neighbors within 1 kb. Replicate samples were combined
by taking the geometric mean of the X and X p values for each probe. A probe
is called bound if the p value of X is < .001 and one of the following conditions is
met: the p value of X < .001 and the p value of either neighboring X is < 0.1 OR
the p value of at least two of three probes (X and its two neighbors) is < .005.
A gene is called bound if any of its probes are called bound. The binding
strength of a gene is defined aslog10p value(X) of its most significantly bound
probe. For histone methylation data, average probe signals were extracted in
500 bp windows as described (Maherali et al., 2007).
Expression Data
RNA was extracted from duplicate samples of V6.5 and E14 ES cells, 1D4 and
2D4 iPS cells, 1A2 and a single sample of 1B3 partially reprogrammed cells,
four samples of three different MEF lines, fibroblasts induced to express
a single factor, and the uninduced control and analyzed on Affymetrix Gene-
Chip Mouse Genome 430 2.0 arrays at the UCLA microarray core facilities.
Quantile normalizationwas performed using the Affymetrix package (affy) (Bio-
conductor). To convert probe data into gene expression data, probes ending in
‘‘_at’’ and ‘‘_a_at’’ were averaged for each gene. All gene expression data are
provided in Table S4. Analysis combining averaged expression data with
binding data was conducted on genes with expression >200 in ES, iPS,
pips, or MEF cells (provided in Table S2). Cluster 3.0 was used for hierarchical
clustering and Java Treeview for visualization.
Computational Methods
The expected number of binding events (Figure 1B) was computed assuming
that binding by each factor is independent of that of the others. Individual
binding probabilities were estimated from ChIP-chip data. Specific binding
events are then the product of the probabilities (for example p(OSK) =
p(Oct4) 3 p(Sox2) 3 p(Klf4) 3 (1-p(c-Myc)). The probability of binding by
a specific number of factors is the sum of the probabilities satisfying that
condition and the expected number for that condition is this probability multi-
plied by the number of genes on the array. For Figure 3B, the hamming
distance, h, of a gene was defined as the number of mismatches in Oct4,
Sox2, c-Myc, and Klf4 binding between ES and iPS cells or ES cells and
partially reprogrammed cells, ranging from 0 for perfect match in binding to
4 for complete mismatch. The number of factors differentially bound between
iPS and partially reprogrammed cells is the average of (h(iPS, ES)h(piPS,ES)).
Significance was determined using the binomial distribution with k equal to the
number of times h(piPS,ES) was greater than h(iPS,ES) in a given ES binding
cluster, (i.e., p value = P(X > = k), where XBin(n,0.5)). Motif scanning was
done using methods developed by Zhou et al. (2007; see Supplemental
Data). Enrichment determined in Figure 6C is the conditional probability of
a gene being 2-fold upregulated in the dox-induced MEF/uninduced MEF
given that a gene is 2-fold up in ES/MEF divided by the marginal probability
of being 2-fold up in dox-induced MEF/uninduced MEF. The hypergeometric
distribution was used to determine significance.
ACCESSION NUMBERS
Data are available at GEO under GSE14012.
SUPPLEMENTAL DATA
Supplemental Data include a detailed description of the motif scanning
method, 10 figures, and 7 tables and can be found with this article online at
http://www.cell.com/supplemental/S0092-8674(09)00007-5.
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